|
|
||||||||
RAPID COMMUNICATION |
a Department of Pathology and Laboratory Medicine, and
b Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Key Words. Hematopoiesis • Megakaryocytopoiesis • FLT3/FLK-2 (STK-1) receptor • FLT3/FLK-2 (STK-1) ligand • Growth factors • Antisense oligodeoxynucleotides
Dr. Alan M. Gewirtz, 513B-Stellar-Chance Laboratories, University of Pennsylvania School of Medicine, 422 Curie Blvd., Philadelphia, PA 19104, USA. e-mail: gewirtz{at}a1.mscf.upenn.edu
It has not yet been determined if the FLT3/FLK-2 or STK-1 Ligand (STK-1 L)/FLT3/FLK-2 or STK-1 receptor (STK-1R) axis has the ability to regulate human megakaryopoiesis in vitro. To address this question, we exposed normal human CD34+ marrow mononuclear cells to recombinant human STK-1L alone, or in combination with other growth factors. Colony-forming unit-megakaryocytic/thrombocytes (CFU-Meg) and BFU-E-derived colonies were then enumerated, and effects on colony size and maturation noted. As assessed by these parameters, STK-1L had no demonstrable effect on megakaryocyte colony formation. Similarly, suppressing STK-1R expression with oligodeoxynucleotides also had no influence on CFU-Meg-derived colony formation. To begin to derive a physiologic explanation for these findings, we examined freshly isolated normal human megakaryocytes for the presence of STK-1L and STK-1R mRNA. In contrast to a growing number of growth factors and growth factor receptors which appear to be expressed by megakaryocytes, normal mature human megakaryocytes express neither STK-1R or STK-1L mRNA. Accordingly, our results led us to hypothesize that if STK-1/ STK-1L have any effects on megakaryocyte development in vitro, they are likely subtle and of uncertain physiologic significance.
This article has been cited by other articles:
![]() |
J. L. Williams, G. G. Pipia, N. S. Datta, and M. W. Long Thrombopoietin Requires Additional Megakaryocyte-Active Cytokines for Optimal Ex Vivo Expansion of Megakaryocyte Precursor Cells Blood, June 1, 1998; 91(11): 4118 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
